Windtree Therapeutics

Windtree Therapeutics, Inc. is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Windtree Therapeutics, Inc. is advancing late-stage interventions for cardiovascular diseases to treat patients in moments of crisis. Using new scientific and clinical approaches, Windtree’s lead candidate istaroxime is being developed as a first-in-class treatment for cardiogenic shock and acute heart failure.